您的位置: 首页 > 农业专利 > 详情页

Novel N,N-hydrazino-bis-isatin derivatives with selective activity against multidrug-resistant cancer cells
专利权人:
发明人:
申请号:
EP11160557.2
公开号:
EP2508512B1
申请日:
2011.03.31
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
The invention, is directed to a compound of Formula (I),wherein R is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group R1 is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group X is selected from the group consisting of hydrogen atom or halogen atom and Y is selected from the group consisting of hydrogen atom, halogen atom, C1-C4 alkyl group, nitro group, and -OCF3 group, as well as for its use in therapy, preferably for the treatment of cancer, and to a related pharmaceutical composition, the use of the compound for the manufacture of a medicament for the respective medical indication, and a method of synthesis of the compounds of the invention.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充